Abpro Bio Co., Ltd.

KOSDAQ:A195990 Stock Report

Market Cap: ₩123.8b

Abpro Bio Past Earnings Performance

Past criteria checks 0/6

Abpro Bio has been growing earnings at an average annual rate of 21.6%, while the Machinery industry saw earnings growing at 17.8% annually. Revenues have been declining at an average rate of 6.6% per year.

Key information

21.6%

Earnings growth rate

39.4%

EPS growth rate

Machinery Industry Growth18.9%
Revenue growth rate-6.6%
Return on equity-5.3%
Net Margin-25.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Abpro Bio Co., Ltd. (KOSDAQ:195990) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

Dec 06
Abpro Bio Co., Ltd. (KOSDAQ:195990) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

We Think Abpro Bio (KOSDAQ:195990) Has A Fair Chunk Of Debt

Oct 21
We Think Abpro Bio (KOSDAQ:195990) Has A Fair Chunk Of Debt

Getting In Cheap On Abpro Bio Co., Ltd. (KOSDAQ:195990) Is Unlikely

Jul 12
Getting In Cheap On Abpro Bio Co., Ltd. (KOSDAQ:195990) Is Unlikely

Revenues Not Telling The Story For Abpro Bio Co., Ltd. (KOSDAQ:195990)

Mar 14
Revenues Not Telling The Story For Abpro Bio Co., Ltd. (KOSDAQ:195990)

Is Abpro Bio (KOSDAQ:195990) Using Debt In A Risky Way?

Apr 05
Is Abpro Bio (KOSDAQ:195990) Using Debt In A Risky Way?

Abpro Bio (KOSDAQ:195990) Shareholders Booked A 92% Gain In The Last Year

Feb 02
Abpro Bio (KOSDAQ:195990) Shareholders Booked A 92% Gain In The Last Year

Revenue & Expenses Breakdown

How Abpro Bio makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A195990 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2427,416-6,89210,281500
30 Jun 2418,585-20,16210,383573
31 Mar 2423,327-22,4529,332557
31 Dec 2325,375-25,7429,832573
30 Sep 2325,836-16,07410,766674
30 Jun 2325,873-11,93311,166660
31 Mar 2324,851-10,47511,616767
31 Dec 2222,112-8,14511,117880
30 Sep 2220,595-11,9378,276788
30 Jun 2224,674-6,5907,773812
31 Mar 2226,136-11,1698,964692
31 Dec 2132,914-9,2557,783562
30 Sep 2142,613-33,6318,111563
30 Jun 2145,552-37,6167,183553
31 Mar 2143,897-39,6675,381563
31 Dec 2035,797-42,1106,041519
30 Sep 2024,386-29,5747,6901,240
30 Jun 2015,585-40,7428,2181,768
31 Mar 2020,995-33,92511,1831,857
31 Dec 1931,930-32,72412,4561,985
30 Sep 1936,110-20,84210,2621,627
30 Jun 1953,787-9,33711,460953
31 Mar 1960,322-10,8119,382987
31 Dec 1858,857-9,3908,6591,213
30 Sep 1866,323-7,13611,583964
30 Jun 1854,066-11,11811,739964
31 Mar 1850,929-7,44911,818980
31 Dec 1745,944-11,62612,0521,369
30 Sep 1738,589-8,26711,3841,585
30 Jun 1742,120-6,12511,6451,585
31 Mar 1743,467-4,61511,1211,629
31 Dec 1649,5211710,2691,540
30 Sep 1653,1282,5818,0501,453
30 Jun 1650,7683,7946,8161,453
31 Mar 1664,1305,6017,4041,426
31 Dec 1577,10115,0217,3701,498
30 Sep 1595,49619,5678,7901,416
30 Jun 15109,43925,2118,7941,416
31 Mar 1597,01823,2917,3431,756
31 Dec 1485,99914,7517,1561,318

Quality Earnings: A195990 is currently unprofitable.

Growing Profit Margin: A195990 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A195990 is unprofitable, but has reduced losses over the past 5 years at a rate of 21.6% per year.

Accelerating Growth: Unable to compare A195990's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A195990 is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (-0.3%).

Return on Equity

High ROE: A195990 has a negative Return on Equity (-5.29%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 07:03
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abpro Bio Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kyung Jun MoonMERITZ Securities Co., Ltd.